ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Theradex


Include trials that are no longer recruiting patients.

15 studies were found.
1.No longer recruitingBAY 59-8862 in Treating Patients With Advanced Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
2.SuspendedBAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma
Conditions: recurrent grade III follicular large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; ...
3.No longer recruitingBBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
Conditions: stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
4.No longer recruitingBBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment
Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
5.No longer recruitingChemotherapy in Treating Patients With Metastatic Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
6.RecruitingCombination Chemotherapy and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
7.No longer recruitingCombination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent grade III follicular large cell lymphoma; recurrent cutaneous T-cell lymphoma; ...
8.No longer recruitingDHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
9.No longer recruitingDHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
Conditions: recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
10.No longer recruitingDHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
11.No longer recruitingPaclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
Conditions: stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; Quality of Life; squamous cell carcinoma of the esophagus
12.No longer recruitingPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Conditions: Nose Cancer; Oral Cancer
13.No longer recruitingPaclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer
14.RecruitingPixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
Conditions: recurrent adult diffuse large cell lymphoma; anaplastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
15.No longer recruitingWeekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer; ...

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act